Residual genomic profile after cyclosporine treatment may offer insights into atopic dermatitis reoccurrence

Journal of Allergy and Clinical Immunology

Volumn 134, Issue 4, 2014, Pages 955-957

  Rozenblit, Mariya ^a,b   Suarez Farinas, Mayte ^a   Shemer, Avner ^c   Khattri, Saakshi ^a   Gilleaudeau, Patricia ^a   Sullivan Whalen, Mary ^a   Zheng, Xiuzhong ^a   Xu, Hui ^a   Cardinale, Irma ^a   Krueger, James G ^a   Guttman Yassky, Emma ^a,b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c Tel Hashomer ^*  (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CYCLOSPORIN; CYCLOSPORIN A; CLAUDIN; CLAUDIN 8; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; LEPTIN; PHARMACOLOGICAL BIOMARKER; TRANSCRIPTOME;

ATOPIC DERMATITIS; DRUG CHOICE; GENOMICS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MINIMAL RESIDUAL DISEASE; PHENOTYPE; PHOTOTHERAPY; RECURRENT DISEASE; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRAVIOLET B RADIATION; CELL CULTURE; CLINICAL PROTOCOL; COMPARATIVE STUDY; DERMATITIS, ATOPIC; DRUG EFFECTS; FOLLOW UP; GENETICS; GENOME; IMMUNOLOGY; METABOLISM; RADIATION RESPONSE; T LYMPHOCYTE SUBPOPULATION; TH2 CELL; TREATMENT OUTCOME;

BIOMARKERS, PHARMACOLOGICAL; CELLS, CULTURED; CLAUDINS; CLINICAL PROTOCOLS; CYCLOSPORINE; DERMATITIS, ATOPIC; FOLLOW-UP STUDIES; GENOME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; LEPTIN; RECURRENCE; T-LYMPHOCYTE SUBSETS; TH2 CELLS; TRANSCRIPTOME; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 84908150155     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2014.05.024     Document Type: Article

References (9)

1. S. Khattri, A. Shemer, M. Rozenblit, N. Dhingra, T. Czarnowicki, and R. Finney Cyclosporine A in atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology J Allergy Clin Immunol 133 2014 1626 1634
2. M. Suarez-Farinas, J. Gittler, A. Shemer, I. Cardinale, J.G. Krueger, and E. Guttman-Yassky Residual genomic signature of atopic dermatitis despite clinical resolution with narrow-band UVB J Allergy Clin Immunol 131 2012 577 579
3. D.Y. Leung New insights into atopic dermatitis: a role of skin barrier and immune dysregulation Allergol Int 62 2013 151 161
4. G.D. Bandow, and J.Y. Koo Narrow-band ultraviolet B radiation: a review of the current literature Int J Dermatol 43 2004 555 561
5. H. Granlund, P. Erkko, M. Sinisalo, and S. Reitamo Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy Br J Dermatol 132 1995 106 112
6. J. Su, T. Chen, X.Y. Ji, C. Liu, P.K. Yadav, and R. Wu IL-25 downregulates Th1/Th17 immune response in an IL-10 dependent manner in inflammatory bowel disease Inflamm Bowel Dis 19 2013 720 728
7. S. Ali, A. Mohs, M. Thomas, J. Klare, R. Ross, and M.L. Schmitz The dual function cytokine IL-33 interacts with the transcription factor NF-kB to dampen NF-kB stimulated gene transcription J Immunol 187 2011 1609 1616
8. P. Stoitzner The Langerhans cell controversy: are they immunostimulatory or immunoregulatory cells of the skin immune system? Immunol Cell Biol 88 2010 348 350
9. C. Flohr, and J. Mann New insights into the epidemiology of childhood atopic dermatitis Allergy 69 2014 3 16